Stay updated on Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    - Revision log updated: v3.5.0 added and v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-20T00:10:54.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T21:16:12.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Update timestamps were added/adjusted on the page, reflecting recent edits to the record. No changes to the study design, eligibility criteria, or outcomes were observed.
    Difference
    0.3%
    Check dated 2026-02-19T05:33:56.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added; notices for Revision: v3.4.1 and the government funding status alert were removed.
    Difference
    0.5%
    Check dated 2026-02-12T02:10:42.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with status update for the NIH Clinical Center, and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-04T11:57:49.000Z thumbnail image
  8. Check
    52 days ago
    Change Detected
    Summary
    The page now displays the glossary toggle, updates QA-related labels with capitalization changes (Last Update Submitted that Met QC Criteria / No FEAR Act Data), and upgrades the revision to v3.4.0.
    Difference
    0.2%
    Check dated 2026-01-28T11:13:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Brentuximab in Hodgkin Lymphoma Clinical Trial page.